Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion

Abstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may infl...

Full description

Saved in:
Bibliographic Details
Main Authors: Sudong Liu, Xiaodong Gu, Ruiqiang Weng
Format: Article
Language:English
Published: Wiley 2021-12-01
Series:Immunity, Inflammation and Disease
Subjects:
Online Access:https://doi.org/10.1002/iid3.474
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850074429650894848
author Sudong Liu
Xiaodong Gu
Ruiqiang Weng
author_facet Sudong Liu
Xiaodong Gu
Ruiqiang Weng
author_sort Sudong Liu
collection DOAJ
description Abstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may influence the outcome of LIT. Methods This study included a total of 704 URSA patients, of which 444 patients accepted LIT treatment. URSA patients that did not accept LIT served as control group. Clinical characteristics were collected and analyzed between LIT and control group. The blocking antibody was tested before and after LIT. The outcome of LIT treatment was recorded. Logistic regression analysis was applied to evaluate the independent predictors of LIT success. Results After LIT treatment, 77.9% (346/444) of USRA patients turned to BA positive, and the conversion rate elevated with increased LIT (p < .001). LIT significantly improved the pregnancy rate and live birth rate in USRA patients (65.3% vs. 29.6%, p < .001; 80.3% vs. 50.6%, p < .001). Multivariate regression analysis suggested that younger maternal age and positive BA were independent predictors of LIT success. Conclusion LIT effectively induced the production of BA, and improved pregnancy rate and live birth rate in URSA patients. Our findings supported LIT as a beneficial treatment for URSA.
format Article
id doaj-art-f56433f4d85b4e2ab3a9d3eb2ba68e6c
institution DOAJ
issn 2050-4527
language English
publishDate 2021-12-01
publisher Wiley
record_format Article
series Immunity, Inflammation and Disease
spelling doaj-art-f56433f4d85b4e2ab3a9d3eb2ba68e6c2025-08-20T02:46:35ZengWileyImmunity, Inflammation and Disease2050-45272021-12-01941272127810.1002/iid3.474Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortionSudong Liu0Xiaodong Gu1Ruiqiang Weng2Research Experimental Center, Meizhou People's Hospital (Huangtang Hospital) Meizhou Hospital Affiliated to Sun Yat‐sen University Meizhou ChinaResearch Experimental Center, Meizhou People's Hospital (Huangtang Hospital) Meizhou Hospital Affiliated to Sun Yat‐sen University Meizhou ChinaResearch Experimental Center, Meizhou People's Hospital (Huangtang Hospital) Meizhou Hospital Affiliated to Sun Yat‐sen University Meizhou ChinaAbstract Introduction Lymphocyte immunotherapy (LIT) is believed to be a viable treatment for unexplained recurrent spontaneous abortion (URSA), but its effect remains controversial. This study aims to investigate the clinical effect of LIT in patients with URSA and clarify the factors that may influence the outcome of LIT. Methods This study included a total of 704 URSA patients, of which 444 patients accepted LIT treatment. URSA patients that did not accept LIT served as control group. Clinical characteristics were collected and analyzed between LIT and control group. The blocking antibody was tested before and after LIT. The outcome of LIT treatment was recorded. Logistic regression analysis was applied to evaluate the independent predictors of LIT success. Results After LIT treatment, 77.9% (346/444) of USRA patients turned to BA positive, and the conversion rate elevated with increased LIT (p < .001). LIT significantly improved the pregnancy rate and live birth rate in USRA patients (65.3% vs. 29.6%, p < .001; 80.3% vs. 50.6%, p < .001). Multivariate regression analysis suggested that younger maternal age and positive BA were independent predictors of LIT success. Conclusion LIT effectively induced the production of BA, and improved pregnancy rate and live birth rate in URSA patients. Our findings supported LIT as a beneficial treatment for URSA.https://doi.org/10.1002/iid3.474blocking antibody (BA)live birth ratelymphocyte immunotherapy (LIT)unexplained recurrent spontaneous abortion (URSA)
spellingShingle Sudong Liu
Xiaodong Gu
Ruiqiang Weng
Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
Immunity, Inflammation and Disease
blocking antibody (BA)
live birth rate
lymphocyte immunotherapy (LIT)
unexplained recurrent spontaneous abortion (URSA)
title Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_full Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_fullStr Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_full_unstemmed Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_short Clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
title_sort clinical effect of lymphocyte immunotherapy on patients with unexplained recurrent spontaneous abortion
topic blocking antibody (BA)
live birth rate
lymphocyte immunotherapy (LIT)
unexplained recurrent spontaneous abortion (URSA)
url https://doi.org/10.1002/iid3.474
work_keys_str_mv AT sudongliu clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion
AT xiaodonggu clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion
AT ruiqiangweng clinicaleffectoflymphocyteimmunotherapyonpatientswithunexplainedrecurrentspontaneousabortion